Latest news
Context Therapeutics Inc (CNTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 09:16:53 GMTContext Therapeutics Inc. Stock 12‑Month Price Target Cut to $4.56, Implies 557% Upside - TradingViewTradingView · Thu, 06 Aug 2026 23:20:13 GMTKey facts: NASDAQ:CNTX to dose CT-202 in Q3'26; shares -30%; $5 target - TradingViewTradingView · Thu, 06 Aug 2026 07:14:59 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - TradingViewTradingView · Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Ends CT-95, Focuses on Two Cancer Programs - Stock TitanStock Titan · Thu, 06 Aug 2026 01:23:30 GMTContext Therapeutics (NASDAQ:CNTX) Announces Earnings Results, Misses Expectations By $0.05 EPS - MarketBeatMarketBeat · Thu, 06 Aug 2026 01:20:01 GMTCNTX 8-K & SEC Filings - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 00:41:17 GMTContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:44:29 GMT